Abstract:Background: N6-methyladenosine (m6A) modification is a part of epigenetic research that has gained increasing attention in recent years. m6A modification is widely involved in many biological behaviors of intracellular RNA by regulating mRNA, thus affecting disease progression and tumor occurrence. However, the effects of m6A modification on immune cell infiltration of the tumor microenvironment (TME) are uncertain in stomach adenocarcinoma (STAD). Methods: The Cancer Genome Map (TCGA) database was used to download transcriptome data, clinicopathological data, and survival data for m6A-regulated genes in 433 STAD tissues that meet the requirements of this study. GSE84437 data were obtained from the Gene Expression Omnibus (GEO) database. The correlation between 23 m6A regulated genes was analyzed using R software. Sample clustering analysis was carried out on the genes of the m6A regulatory factor, and survival analysis and differentiation comparison were made for patients in clustering grouping. Then, the Gene Set Enrichment Analysis (GSEA), the single-sample GSEA (ssGSEA), and other methods were conducted to assess the correlation among m6A modification patterns, TME cell infiltration characteristics, and immune infiltration markers. The m6A modification pattern of individual tumors was quantitatively evaluated using the m6A score scheme of the principal component analysis (PCA). Results: From the TCGA database, 94/433 (21.71%) samples were somatic cell mutations, and ZC3H13 mutations are the most common. Based on the consensus, matrix k-3 is an optimal clustering stability value to identify three different clusters. Three types of m6A methylation modification patterns were significantly different in immune infiltration. Thus, 1028 differentially expressed genes (DEGs) were identified. The survival analysis of the m6A score found that patients in the high m6A score group had a better prognosis than those in the low m6A score group. Further analysis of the survival curve combining tumor mutation burden (TMB) and m6A scores revealed that patients had a significantly lower prognosis in the low tumor mutant group and the low m6A score group ( p = 0.003). The results showed that PD-L1 was significantly higher in the high m6A score group than in the low score group ( p < 2.22e-16). The high-frequency microsatellite instability (MSI-H) subtype score was significantly different from the other two groups. Conclusions: This study systematically evaluated the modification patterns of 23 m6A regulatory factors in STAD. The m6A modification pattern may be a critical factor leading to inhibitory changes and heterogeneity in TME. This elucidated the TME infiltration characteristics in patients with STAD through the evaluation of the m6A modification pattern.

N6-methyladenosine methylation modification patterns reveal immune profiling in pancreatic adenocarcinoma

Abstract 4827: N6-Methyladenosine Modification of LINC00901 Promotes Pancreatic Cancer Progression

A Prognostic Model of M6a-Related Lipid Metabolism-Associated Genes in Pancreatic Adenocarcinoma

The Regulation of N6‐methyladenosine Modification in PD‐L1‐induced Anti‐tumor Immunity

N6-methyladenosine Modification: an Important Player in the Tumor Immune Microenvironment.

The role of m6A-related genes in the prognosis and immune microenvironment of pancreatic adenocarcinoma

Molecular Characterization and Prognostic Relevance of M6a Regulators in Pancreatic Adenocarcinoma

N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma

Research advances of N6‐methyladenosine in diagnosis and therapy of pancreatic cancer

The N6-Methyladenosine- (M6a-) Associated Genes Act As Strong Key Biomarkers for the Prognosis of Pancreatic Adenocarcinoma

Characterization of Modification Patterns, Biological Function, Clinical Implication, and Immune Microenvironment Association of m6A Regulators in Pancreatic Cancer

Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer

Link between m6A modification and infiltration characterization of tumor microenvironment in lung adenocarcinoma

N6-methyladenosine (m6A) regulator expression pattern correlates with the immune landscape in lung adenocarcinoma.

Role of N6-methyladenosine Regulated Lncrnas in Prognosis, Tumor Microenvironment and Immune Checkpoints of Pancreatic Ductal Adenocarcinoma

N6-Methyladenosine in Cancer Immunotherapy: an Undervalued Therapeutic Target

Comprehensive Analysis Revealed the Potential Implications of m6A Regulators in Lung Adenocarcinoma

The Expression of M6a Regulators Correlated with the Immune Microenvironment Plays an Important Role in the Prognosis of Pancreatic Ductal Adenocarcinoma

An integrated model of N6-methyladenosine regulators to predict tumor aggressiveness and immune evasion in pancreatic cancer

N6-methyladenosine (m6a) RNA Modification in Tumor Immunity

M6a Regulator-Mediated Methylation Modification Highlights Immune Infiltration Patterns for Predicting Risk in Hepatocellular Carcinoma.